ANZUP conducts clinical trial research to improve treatment of Bladder, Kidney, Testicular, and Prostate Cancers

ANZUP Annual Scientific Meeting

The next ASM will be held 16-18 July 2017, Pullman Albert Park, Melbourne. Please save the date.

Thank you to everyone who made the 2016 ASM possible. Program highlights included:

  • State of the art presentations from leading international and Australian experts;

  • Evening Symposium held on July 10. The evening focused on the theme of 'getting the message out' and features guest speakers Dr John Oliffe and Dean F. Bajorin.

  • Up-to-date management and research for prostate and other genitourinary cancers
  • Opportunities for researchers to present their research;

  • Clinical trial Concept Development Workshop;

  • Overviews of current and planned ANZUP trials;

  • ANZUP MDT Masterclass; &

  • Community Engagement Forum - A Little Below the Belt

International Guest Speakers:

Dean F. Bajorin, M.D.

Dean F. Bajorin, M.D., is an Attending Physician in the Genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Centre and Professor of Medicine at Weill Medical College of Cornell University where he oversees the clinical research program in advanced urothelial cancer. He has twice served as chair of the Genitourinary Scientific Committee for the American Society of Clinical Oncology and has authored or co-authored over 150 manuscripts. Dr Bajorin has been the Program Director of the Medical Oncology/Haematology Fellowship Program since 1994, is past Chair of the American Society of Clinical Oncology Training Programs Committee, and is nationally recognised for postgraduate training of clinical investigators in Medical Oncology.

Sponsored by Ipsen

Piet Ost M.D, PhD

Piet Ost M.D. is a radiation oncologist, senior clinical investigator and assistant Professor at the University of Ghent in Belgium. A/Prof Ost’s PhD thesis was on dose-escalation in the postoperative prostate cancer setting and his current research interest is in the treatment of oligometastatic prostate cancer with metastasis-directed therapy and more specifically stereotactic body radiotherapy. Recent work includes the potential influence of radiotherapy on the immune system specifically in renal cell carcinoma exploring the synergistic immunomodulatory properties of radiotherapy.

Sponsored by ANZUP
Dr John Oliffe

Dr. John Oliffe is a Professor at the School of Nursing at the University of British Columbia. Founder and lead investigator of UBC's Men's Health Research program (, his work focuses on masculinity as it influences men's health behaviors and illness management, and its impact on partners, families and overall life quality. An ex-pat Australian Dr. Oliffe has attracted more than $20 million in research funding and published 170 peer reviewed articles since being recruited to UBC in 2003.

Sponsored by ANZUP

Please click here for the 2016 ASM Program.
© ANZUP 2016. All rights reserved. Privacy Policy | Disclaimer | Copyright


Please enter your username and password.


Password Forgot Password?